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Subcellular compartmentalisation and the intracellular movement of nuclear receptors are major regulatory
steps in executing their transcriptional function.Though significant progress has been made in understanding
these regulatory processes in cultured mammalian cells, such results have rarely been confirmed within cells
of a living mammal.This article describes a simple, time-efficient approach to study the nuclear versus
cytoplasmic accumulation of nuclear receptors and the regions of nuclear receptor proteins that govern
subcellular trafficking within hepatocytes of live mice. Pregnane X receptor, a xenobiotic-activated member
of the nuclear receptor family, was used to exemplify the approach. Using dual-labeled wild-type and mutant
PXR expression constructs, we outline their in vivo delivery, simultaneous cellular expression, visualization
and categorical classification within hepatocytes of live mice. Using this approach, we identified three mutants
that had an altered subcellular distribution in the presence and absence of a PXR ligand.This novel in vivo
method complements the current cell culture-based experimental systems in protein subcellular localisation
studies.
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Introduction
Intracellular compartmentalisation is a major regulatory
step for the function of many proteins.This is especially
true for ligand-activated transcription factors such as
nuclear receptors (NR) that depend on nuclear localisation
to exert transcriptional regulation of their target genes.
Analysis of the factors controlling the movement of
nuclear receptors within cells, especially
nuclear/cytoplasmic shuffling, is vital for understanding
nuclear receptor action and is the subject of intense
investigation [Griekspoor et al., 2007].While cultured
mammalian cells are commonly utilised to analyse the
subcellular distribution of nuclear receptors and to dissect
the structural features that govern their localisation, such
results have rarely been confirmed in vivo within cells of
a living mammal.
This article describes a simple, time-efficient approach
to study the nuclear versus cytoplasmic accumulation of
nuclear receptors and the regions of nuclear receptor
proteins that govern subcellular trafficking within livers of
intact mice. Using the pregnane X receptor (NR1I3; PXR),
a xenobiotic-activated member of the nuclear receptor
family [Matic et al., 2007] to exemplify the approach, we
outline the in vivo delivery, simultaneous expression,
visualization and categorical classification of
bioengineered, dual-labeled wild-type and mutant PXR
proteins within the same hepatocyte in livers isolated from
mice following in vivo administration of expression
constructs.
Reagents and instruments
pEYFP-C1 and pECFP-C1 vectors (ClonTech, BD
Biosciences, Mountain View, CA); pGEM-T vector, EcoRI
and XhoI restriction enzymes (Promega, Sydney,
Australia);Tissue-Tek
® O.C.T. compound (Sakyra
Finetek, Torrence, CA); QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA); SuperScript
III cDNA First-Strand Synthesis System, Prolong Gold
mounting agent and Trizol reagent (Invitrogen, Mulgrave,
Victoria, Australia); Hoechst 33258 (Sigma, New South
Wales, Australia); DNase I (Ambion, Austin, TX, USA);
pregnenolone 16α-carbonitrile [PCN; ICN Biomedicals,
Aurora, Ohio]; GFP (FL): sc-8334 antibody (Santa-Cruz
Biotechnology, Santa Cruz, CA, USA);
Immunoprecipitation Kit [Protein G] (Roche, Indianapolis,
IN, USA); Supersignal West Femto Maximum Sensitivity
Substrate (Pierce Chemical Co., Rockford, ILL, USA).
Biorad mini-PROTEAN 3 cell system and Biorad
TRANS-BLOT system (Biorad, Hercules, CA); Shandon
cryotome E Cryostat (Thermo Fisher Scientific, Waltham,
MA); Olympus BX51 Fluorescent microscope (Olympus,
Victoria, Australia); Spot Advanced RT Software Version
3.4 (Diagnostic Instruments, Sterling Heights, MI); Leica
DMIRE inverted microscope, Leica HCX Plan Apochromat
CS 100X Oil Objective (NA 1.4), HC Plan Fluotar 20 X
Ph2 objective (NA 0.5) and Leica TCS2-MP confocal
imaging system (Leica Laserteknik, Mannheim, Germany);
Argon ion laser and a Coherent Mira tuneable pulsed
titanium sapphire laser (Coherent Laser Group, Santa
Clara, CA).
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Expression plasmids
The N-terminal Yellow Fluorescent Protein (YFP) tagged
mPXR431 and mPXRΔ171-211 (YFP-mPXR431 and
YFP-mPXRΔ171-211, respectively) mammalian expression
constructs were generated by PCR amplification of
mPXR431 and mPXRΔ171-211 cDNA fragments derived
from total mouse liver RNA using the following primers:
(F); 5-TATTCTCGAGCT(ATG)AGACCTGAGGAGAGC-3'
XhoI restriction site, (Start codon) and (R);
5'-TGCGAATTCAGCC(ACT)CAGCCATCTGTGCT-3',
(Stop codon), EcoRI restriction site.The primers
incorporated a XhoI restriction site and a CT base
insertion (to maintain an open reading frame) immediately
upstream of the mPXR start codon. An EcoRI restriction
site was incorporated downstream of the stop codon.The
amplicon was ligated into the pGEM-T vector then
digested using EcoRI and XhoI followed by sub-cloning
into the EcoRI and XhoI sites of the pEYFP-C1 expression
vector.The 46 amino acid C-terminal mPXR431 truncation
mutant, YFP-mPXRL385X, was generated by PCR
amplification using YFP-mPXR431 as template and the
following primers: (F);
5-TATTCTCGAGCT(ATG)AGACCTGAGGAGAGC-3',
XhoI restriction site, (Start codon) and (R);
5'-TCCGAATTC(TCA)GAACCTGTGAGCAGGATATGG-3',
EcoRI restriction site, (Stop codon). An EcoRI and XhoI
digest facilitated insertion of the amplicon into the
respective pEYFP-C1 sites.The N-terminal Cyan FP
(CFP) tagged mPXR431 (CFP-mPXR431) was generated
by EcoRI and XhoI excision of mPXR431 fragment from
YFP-mPXR431 and inserting it into the respective
pECFP-C1 sites.The C-terminal CFP tagged mPXR431
(mPXR431-CFP) was generated by PCR amplification
using YFP-mPXR431 as a template and the following
primers; (F); 5-ATCTCGAG
CGCCACC(ATG)AGACCTGAGGAGAGCTGG-3' XhoI
restriction site, Kozak Translation Sequence, (Start
codon) and (R); 5'-GGAATTC
GGCCATCTGTGCTGCTAAATAACTCTTGC-3', EcoRI
restriction site.These primers incorporated a Kozak
translation sequence immediately upstream of the start
codon to ensure efficient start of translation. Furthermore,
they eliminated the stop codon by replacing it with a single
G base, ensuring an open reading frame from mPXR431
into CFP. All other mutants were generated with the
QuikChange site-directed mutagenesis kit, using
pEYFPC1-mPXR431 or pEYFPC1-mPXRΔ171-211 as a
starting template. All PXR expression constructs were
verified by sequencing.
Expression of naked plasmid DNA in
hepatocytes of a live mouse
Animal experimentation was performed on a protocol
approved by Sydney South-west Area Health Service
animal welfare committee. Plasmid DNA (pDNA)
constructs were delivered into the livers of live mice
(n=1-3) via hydrodynamic tail vein injection [Liu et al.,
1999; Sueyoshi et al., 2002; Zhang et al., 1999]. Male
wild-type FVB strain mice (10-14 weeks old; 25-30g) were
anaesthetised with diethyl ether immediately prior to
injection.Tail veins were dilated by immersion in 60°C
water for ~1-2 min.Ten μg of each pDNA construct was
mixed with sterile saline solution (0.9 %w/v) in a volume
equivalent to 10% of the total mouse body weight.The
solution was administered with a rapid (5-10s) but steady
force into the tail vein of the mouse.Twenty-four hours
post injection, the mice were culled, liver pieces excised
and either snap frozen in liquid nitrogen or immediately
embedded in Tissue-Tek
® O.C.T. compound on dry ice.
Liver tissue was stored at -70°C for subsequent analysis.
Histological processing and visualisation of
PXR/fluorescent fusion proteins
Frozen liver sections were cryosectioned at 16μm using
a Shandon cryotome E Cryostat, and every fourth
consecutive section retained on a glass slide to ensure
representation of different cellular regions. Retained
sections were air-dried, fixed in ice-cold acetone for 5min
then air-dried for a second time. Sections were
counterstained with Hoechst 33258 (1μg/ml in PBS/5min),
washed in Phosphate Buffered Solution (PBS: Sodium
chloride, 145 mM (0.85%) in phosphate buffer (150 mM),
air-dried and mounted with Prolong Gold. Samples were
cured for 24h at 4°C away from light then sealed with
clear nail polish.
Fluorescence was observed and captured (Figure 1) with
the Olympus BX51 microscope. For all other studies, liver
sections were observed by fluorescence microscopy using
a Leica DMIRE inverted microscope and a Leica HCX
Plan Apochromat CS 100X Oil Objective, NA 1.4 or a HC
Plan Fluotar 20 X Ph2 objective, NA 0.5. Confocal images
were then collected using a Leica TCS2-MP confocal
imaging system equipped with an argon ion laser and a
Coherent Mira tuneable pulsed titanium sapphire laser.
Samples containing Hoechst 33342 were excited using
λex = 780 nm (titanium sapphire laser) with pulses in the
100-200 fs range, and detected at λem = 420 to 450 nm.
Samples containing CFP were excited using λex = 458
nm (Ar laser), and detected at λem = 470-490 nm.
Samples containing YFP were excited using λex = 514
nm (Ar laser), and detected at λem = 530-550 nm. Images
were acquired as 8 bit images in at least a 1024 X 1024
pixel array with a scan rate of 400 Hz and line averages
were performed at 6-8 scans per image.
Ligand treatment
Five and 20 hours following delivery of PXR/fluorescent
protein expression constructs, mice were administered
the PXR-specific ligand pregnenolone 16α-carbonitrile
(PCN; 80 mg/kg; ip), or dimethylsulfoxide vehicle.
cDNA synthesis
Total RNA was isolated from mouse liver using Trizol
reagent and treated with DNase I according to the
manufacturer’s protocols. Complementary DNA was
synthesized from 5μg of total RNA with SuperScript III
cDNA First-Strand Synthesis System using random
hexamer primers.
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Methods In vivo analysis of nuclear receptor subcellular distributionFigure 1.  Expression of YFP-mPXR431 in the livers of intact mice. A. Following the hydrodynamic injection of YFP-mPXR431 expression
construct, fluorescence patterns were evident across liver sections of control (i) and ligand (PCN) (ii) treated mice that differed from those of YFP
expression alone. B. Immunoprecipitation of YFP-mPXR431 from mouse liver samples indicated a protein band corresponding to the predicted molecular
weight of the YFP/PXR fusion protein. C. Subcellular distribution patterns of YFP-mPXR431 expression were categorised into 3 distinct categories. An
exclusively nuclear (N), where the fluorescence was confined to the nucleus, a predominantly nuclear (N>C), where a predominant nuclear localisation
was evident with some cytoplasmic fluorescence, and an equal distribution (N=C), where nuclear and cytoplasmic fluorescence was evenly distributed
across the cell. Nuclei are indicated by blue colour, following Hoechst 33250 staining.
Immunoprecipitation and immunodetection
Immunopurification of tissue-expressed fluorescent
proteins was carried out using the GFP (FL): sc-8334
antibody and the Immunoprecipitation Kit [Protein G]
according to the manufacturer’s instructions.
Equal volumes of immunoprecipitated
YFP-mPXR431-transfected and control tissue samples
were resolved on 10% SDS-PAGE using the Biorad
mini-PROTEAN 3 cell system. Proteins were transferred
to polyvinyldifluoridine (PVDF) membrane using the
Biorad TRANS-BLOT system and detected using the GFP
(FL): sc-8334 antibody and the Supersignal West Femto
Maximum Sensitivity Substrate.
Evaluating the functionality of fluorescent
protein recombinants in vivo
The functional validity of in vivo expressed PXR fusion
proteins was carried out through confirmation of correct
molecular weight using Western blot analysis, and
evaluation of ligand-mediated in vivo nuclear localization.
Additional validation could be carried out through
correlation of target gene transcriptional readout in
response to a ligand; however, such analysis needs to
be applied in specific knockout mice in order to eliminate
the effects of endogenously-expressed receptor.
Results
Establishing and evaluating the in vivo
expression system
Following delivery of naked DNA constructs, in vivo
hepatic expression of YFP-mPXR431 was visually
confirmed by fluorescent microscopy (Figure 1A), and
validated by Western analysis to be expressed at ~77kDa
corresponding to the expected size of the mPXR/YFP
fusion protein (Figure 1B). Hepatocytes of control mice
exhibited a variable YFP-mPXR431 subcellular expression
pattern spanning both the nuclear and cytoplasmic cellular
compartments.To validate the functional integrity of
YFP-mPXR431 within the in vivo environment of mouse
livers, mice were treated with the mPXR-specific ligand,
PCN. As expected, following ligand treatment the majority
of hepatocytes exhibited an exclusively nuclear
fluorescence pattern (Figure 1Aii), consistent with
previous observations of nuclear receptor function
following ligand activation [Griekspoor et al., 2007].
Therefore, the YFP-mPXR431 construct used in
subsequent experiments could bind ligand and translocate
to the nucleus of hepatocytes. Having validated and
established the functional and structural integrity of
YFP-mPXR431 and the in vivo hepatic expression
experimental system, we sought to investigate regional
mutations within the PXR protein that could influence its
nuclear versus cytoplasmic accumulation.
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studies
Due to the extensive physiological factors that could
potentially influence the behaviour of transfected mPXR
in different hepatocytes of the same mouse, we chose to
analyse the behaviour of a bioengineered mutant mPXR
protein (MUT) with the wild-type mPXR counterpart (WT;
mPXR431) within the same hepatocyte using dual labelling
techniques.This approach required mutated and wild-type
PXR proteins to be differentially tagged, enabling the
direct comparison of their intracellular distribution patterns
on a cell-by-cell basis.Thus, we chose to use
CFP-mPXR431 and YFP-mPXRMUT for these comparative
studies. CFP and YFP are organic fluorescent proteins
derived from the Green FP, first identified in the jellyfish
Aequorea victoria.YFP and CFP were originally
engineered to obtain altered spectral emission properties
from GFP, as well as each other.They differ by 4 and 6
amino acids (respectively) from the naturally-occurring
GFP. Co-expression of CFP-mPXR431 or mPXR431-CFP
together with YFP-mPXR431 revealed identical
nuclear-cytoplasmic distributions (data not shown), thus
ensuring that differences in fluorescent protein tag
orientation at the N- or C-terminus of mPXR or the
different amino acids in CFP and YFP did not impact on
the subcellular distribution patterns. Once this was
established, analysis of mutants proceeded.
The subcellular distribution of co-expressed
CFP-mPXR431/YFP-mPXRMUT proteins was observed
and scored in at least 200 cells, encompassing a variety
of WT mPXR subcellular distribution states categorised
as exclusively nuclear (N); predominantly nuclear (N>C);
and equal nuclear/cytoplasmic (N=C) (Figure 1C).These
subcellular distribution states of wild-type PXR formed
the basis of qualitative distribution reference categories
(Figure 2) used to comparatively evaluate the localisation
of mPXR mutant protein tagged with CFP within the same
cell.
Mutant analysis
A range of C-terminal truncation, internal deletion and
single or multiple point mutants of mPXR were
bioengineered based on predictive analysis, previous
studies with PXR [Kawana et al., 2003; Squires et al.,
2004] and comparative homology with domains of other
nuclear receptor proteins that determine subcellular
distribution [Black et al., 2001; Hsieh et al., 1998; Zelko
et al., 2001] (Figure 3).
mPXRΔ171-211 is a functional, naturally-occurring mPXR
variant that lacks 41 amino acids spanning the hinge/LBD
interface [Kliewer et al., 1998]. Although it is a significant
mPXR isoform that is conserved in humans [Lamba et
al., 2004], the subcellular distribution of mPXRΔ171-211
had not been investigated.Truncations of the C-terminus
(mPXRL385X and mPXRL425X) were designed to interfere
with the function of xenochemical responsive signal (XRS)
and/or the activation function 2 (AF2) domain reported to
mediate the nuclear translocation of mPXR [Squires et
al., 2004].The mPXRL385X mutant eliminated 46 amino
acids from the C-terminus of mPXR, encompassing the
XRS and the AF2 domain, while the 7 amino acid
truncation (mPXRL425X) was designed to disrupt AF2
function.The amino acid 61-62 phenylalanine to alanine
mutations (i.e., mPXRF61/62A) within the DNA binding
domain of mPXR were derived by sequence homology
to the glucocorticoid receptor [Black et al., 2001] and the
constitutive androstane receptor [Xia and Kemper, 2007],
where they have been identified as being critical for
nuclear export to the cytoplasm.
Quadruple arginine to alanine mutations incorporated in
mPXRR63/64/88/89A and mPXRΔ171-211,R63/64/88/89A were
reported to abolish nuclear localisation ability of PXR in
addition to the lysine encompassed by the four arginines
corresponding to position 67 of mPXR [Kawana et al.,
2003; Squires et al., 2004]. Finally, a search for putative
cytoplasmic to nuclear translocation sequences of mPXR
using PredictNLS [Cokol et al., 2000] revealed a putative
NLS encompassing amino acids 
123KRKKREK
129.The
arginine at position 67 was point mutated to tryptophan
to disrupt the NLS through steric hindrance. mPXR
mutants were analysed in ligand-treated mice to study
mPXR when fully activated by a xenobiotic ligand, as well
as in control mice. Confocal microscopy with appropriate
discriminatory filters for YFP and CFP (Figure 4) indicated
three YFP-mPXR mutants had a substantial change in
subcellular distribution patterns, exhibited as increased
cytoplasmic presence when compared with the wild-type
CFP-mPXR431 reference distributions within the same
cell.
The quad mutant YFP-mPXRR63A/R64A/R88A/R89A (which
has 4 mutated arginine residues adjacent to the zinc
fingers within the DNA binding domain of mPXR)
accumulated in the cytoplasm of 34% (i.e., 30% N>C plus
4% N=C) of the same hepatocytes that displayed an
exclusively nuclear (N) distribution of wild-type
CFP-mPXR431.The effect of mutating these 4 residues
also altered the distribution of YFP-mPXR protein in cells
displaying N>C distribution of CFP-mPXR431, indicating
65% of these hepatocytes displayed an N=C accumulation
of YFP-mPXRR63A/R64A/R88A/R89A.The same four
mutations generated in the mPXR variant (mPXRΔ171-211
variant) retained an increased cytoplasmic presence of
mPXRΔ171-211 in reference to the CFP-mPXR431 wild-type.
YFP-mPXRΔ171-211, R63A/R64A/R88A/R89A was seen as N>C
in 19% and as N=C in 76% of hepatocytes showing a N
and a N>C distribution of CFP-mPXR431, respectively.
The truncation mutant YFP-mPXRL386X, which lacks 25
amino acid residues at the C-terminus, was found to be
distributed as N>C in 17% and N=C in 68% of
hepatocytes that indicated the wild-type CFP-mPXR431
as N and N>C distribution, respectively. Examination of
livers from mice dual transfected with other mutant PXR
constructs did not detect an appreciable number of
hepatocytes (<5%) exhibiting an altered distribution of
mutant YFP-mPXR, as compared with wild-type
CFP-mPXR431 proteins.
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Methods In vivo analysis of nuclear receptor subcellular distributionFigure 3.  Schematic representation of YFP-mPXR mutants.
C-terminal truncations, internal deletions and single or combinatory point
mutants were bioengineered to evaluate their impact on the subcellular
distribution patterns of mouse PXR. CFP, Cyan Fluorescent Protein;YFP,
Yellow Fluorescent Protein; DBD, DNA Binding Domain; LBD, Ligand
Binding Domain. CFP-mPXR431 is the non-mutated wild-type form of
murine PXR.
As expected, in mice treated with the potent
mPXR-specific ligand PCN, the overall distribution of
wild-type CFP-mPXR431 shifted to a more nuclear
accumulation in most hepatocytes (data not shown).
However, mutant YFP-mPXR proteins that displayed
increased cytoplasmic accumulation in untreated mice
also had altered distribution in the presence of PCN (i.e.,
N>C:YFP-mPXRR63A/R64A/R88A/R89A 23%,
YFP-mPXRΔ171-211, R63A/R64A/R88A/R89A 12% and
mPXRL386X 13% in hepatocytes indicating a N distribution
of CFP-mPXR431; N=C:YFP-mPXRR63A/R64A/R88A/R89A
53%, YFP-mPXRΔ171-211, R63A/R64A/R88A/R89A 72% and
mPXRL386X 59% in hepatocytes indicating a N>
distribution of CFP-mPXR431).Therefore, within the same
hepatocytes of mice livers with ligand-activated wild-type
mPXR, these mutant forms of PXR distribute differently.
Figure 2. The categorical approach to comparatively investigate
the subcellular distribution of co-expressed CFP-mPXR431
(CFP-Control; red colour) and YFP-mPXRMUT (YFP-Mutant; green
colour) within the same hepatocyte of the liver. The subcellular
distribution patterns of each expression protein were individually
categorised into a N, N>C or N=C category, then cross-referenced within
the same hepatocyte to form one of 9 different possibilities representing
degrees of differential localisation between the control and mutant protein.
Yellow indicates overlapping distribution.
Discussion
Investigating the in vivo subcellular distribution of nuclear
receptors (NR) is often seen as a daunting task.
Frequently, immunohistochemical analysis is employed
to analyse the distribution of endogenously-expressed
NR, however this approach is highly dependent on the
availability and/or specificity of the applied antibody. Even
so, it is now becoming more evident that nuclear receptors
can have multiple alternate forms (isoforms), which can
be structurally identical for all but a few amino acids.
These protein variants may have alternate subcellular
distribution patterns and/or functional properties. As such,
the existence of identical antibody epitopes shared
between multiple nuclear receptor isoforms, some of
which are yet to be discovered, may mask the subcellular
distribution pattern of the targeted protein.Therefore,
immunohistochemically-derived data needs to be critically
assessed when applied to subcellular distribution studies.
Additional complications arise when in vivo analysis of
mutant variants is desired. Such analysis generally
requires targeted expression of mutant proteins via
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Methods In vivo analysis of nuclear receptor subcellular distributionFigure 4.  Altered subcellular distribution of YFP-tagged mutant PXR compared with CFP-tagged wild-type PXR. Ranges of subcellular
distribution categories were identified (see Figure 2) in a number of cells. Categories indicating decreased cytoplasmic presence of the mutant (with
reference to the control) were not identified. Investigations were carried out in both control and ligand-treated mice. Categorical counts are represented
as percentage of the total number of cells exhibiting a single CFP reference state (i.e., N, N>C or N=C) based on cell number.YFP-mPXRR63/64/88/89A,
YFP-mPXRΔ171-211, R63/64/88/89A and YFP-mPXRL386X showed a substantial alteration in the subcellular distribution, indicative of impaired
intracellular localisation ability.
generation of transgenic mice or production of viral
expression vectors, both of which are time consuming
and laborious.These compounding factors usually
preclude in vivo studies in favour of cell culture-based
systems, which allow transfection and expression of
isoform-specific nuclear receptor expression constructs
and careful manipulation of the experimental environment.
While these immortalised cell lines can be informative,
they lack the complex physiological interactions between
different cell types and tissues in the context of a whole
organism.This is especially true for proteins such as
nuclear receptors, whose action is modulated by
endogenously-synthesised ligands potentially produced
elsewhere within the body.
Our studies outline a simple, time-efficient approach to
study the subcellular distribution of nuclear receptors and
their protein variants in vivo. Using the hydrodynamic tail
vein injection, we achieved efficient hepatic expression
of fluorescently-labeled mPXR constructs (Figure 1A),
that could be rapidly visualized, processed and analysed
within 48hrs of initial injection time.
Initial observations (Figure 1) confirmed the structural
and functional integrity of the expressed proteins and the
in vivo experimental system. Consistent with the model
of nuclear receptor action, ligand-treated mice showed
YFP-mPXR431 proteins focused to the nucleus.
Interestingly, the YFP-mPXR431 subcellular distribution
within the same liver of control mice showed considerable
heterogeneity between nuclear and cytoplasmic cellular
compartments of hepatocytes.These observations,
although novel, were not surprising and could potentially
be attributed to i) known functional differences in liver
zonation patterns and heterogeneous complexity of the
liver as an organ [Malarkey et al., 2005], ii) the dynamic
nature of subcellular nuclear-cytoplasmic shuttling [Kumar
et al., 2006] and iii) the ligand promiscuity of PXR, which
potentiates activation by a range of endogenous and
exogenous compounds [Matic et al., 2007]. Facing such
cell-to-cell variability in the subcellular distribution of
YFP-mPXR431 within livers of mice, we adopted a
cell-by-cell comparative approach, evaluating the mPXR
protein (MUT) with the wild-type mPXR counterpart (WT;
mPXR431) within the same hepatocytes.This ensured
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Methods In vivo analysis of nuclear receptor subcellular distributionmutant variants were analysed under the same
physiological conditions as the reference proteins. Pivotal
to this approach was the use of differential but very
closely related CFP and YFP organic tags fused to the
reference or mutated PXR protein counterparts (Figure
3). As such, a 1:1 ratio of tag to protein was guaranteed
and could be visualised at 100% specificity (for the
expressed protein) by using appropriate fluorescent
microscopy filters.The choice of the CFP and YFP protein
tags has an additional benefit of making the expressed
fusion proteins immediately amenable to protein
interaction analysis via Fluorescent Energy Resonance
Transfer [Griekspoor et al., 2007], thereby providing an
additional level of study.
Utilising a categorical approach based on the variable
distribution states of mPXR431 (Figure 2), we successfully
identified three mPXR431 mutants with altered subcellular
distribution behaviour in reference to the control mPXR431
(Figure 4). Interestingly, only a percentage of the total
cells analysed for the altered distribution mutants
indicated differential distribution compared with wild-type
PXR, suggesting the in vivo distribution of PXR proteins
is likely regulated by additional endogenous factors. Such
observations emphasize the importance of physiological
in vivo factors present in the whole organism, which are
likely absent in cell culture-based systems.
In summary, we report an efficient and generally
applicable technique to analyse protein function in an in
vivo model. Utilising the CFP and YFP as differential
protein tags, we simultaneously visualised and
subsequently analysed multiple protein variants inside
the same cell in an intact organ of a living organism. In
addition, the same samples have the potential to be
analysed for protein-protein interactions between the
co-expressed CFP and YFP fusion proteins through the
use of Fluorescent Energy Resonance Transfer.We also
describe an innovative categorical approach applicable
in the described in vivo system for studying the subcellular
distribution of nuclear receptors.The described technique
is not limited to studies of nuclear receptor subcellular
distribution, but is applicable to many other proteins to
conveniently analyse differential proteins, protein variants
or bioengineered protein alterations within livers of intact
animals.This quick and efficient in vivo approach
complements current cell culture-based experimental
systems to provide valuable in vivo observations of
nuclear receptor protein function.
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